Limited coverage drugs – isavuconazole

Last updated on August 27, 2024

Generic name

isavuconazole

Strength

100 mg

Form

capsules

Special Authority criteria

Approval period

For the treatment of Invasive Mucormycosis (IM) in adults when:

  • Prescribed by infectious disease specialist

​​AND

  • The patient is established on isavuconazole in hospital

8 weeks

Practitioner exemptions

  • None

Special notes

  1. Isavuconazole is not indicated and reimbursed for prophylaxis of IM
  2. PharmaCare coverage of isavuconazole is limited to 600 mg per day for the first two days (loading doses), followed by the expectation to use 200 mg daily (maintenance dosing)

Special Authority request form(s)